Anxiety, defence and the elevated plus-maze
References (76)
- et al.
Lasting effects on rodent anxiety of a single exposure to a cat
Physiol. Behav.
(1993) - et al.
Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety
Eur. J. Pharmacol.
(1993) - et al.
Twenty-two kHz alarm cries to presentation of a predator by laboratory rats living in visible burrow systems
Physiol. Behav.
(1991) - et al.
The characterization and modelling of antipredator defensive behavior
Neurosci. Behav. Rev.
(1990) - et al.
Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety
Behav. Brain Res.
(1993) - et al.
Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze
Eur. J. Pharmacol.
(1990) - et al.
Ethopharmacological analysis of rat behavior on the elevated plus-maze
Pharmacol. Biochem. Behav.
(1994) - et al.
Use of the elevated plus-maze in the search for novel anxiolytic agents
Trends Pharmac. Sci.
(1995) 5-hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research
Pharmac. Ther.
(1995)- et al.
An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs
J. Pharmacol. Toxicol. Meth.
(1993)
Measurement of exploratory behavior in rodents
Effects of benzodiazepine receptor antagonist, flumazenil, on murine antinociceptive and behavioural responses to the elevated plus-maze
Neuropharmacology
(1991)
Ethologically-based animal models of anxiety disorders
Pharmac. Ther.
(1990)
Does neophobia imply fear or anxiety?
Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
J. Neurosci. Meths
(1985)
Evaluation of putative anxiolytics in the elevated plus-maze test
Effects of BOC-CCK-4 and L-365,260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus-maze
Neuropharmacology
(1994)
Anxiety enhancement in the murien elevated plus-maze by immediate prior-exposure to social stressors
Physiol. Behav.
(1993)
Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test
Eur. J. Pharmacol.
(1994)
Ethopharmacological analysis of the effects of putative ‘anxiogenic’ agents in the mouse elevated plus-maze
Pharmacol Biochem. Behav
(1995)
Anti-anxiety and behavioural suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan
Pharmacol. Biochem. Behav.
(1994)
Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze
Pharmacol. Biochem. Behav.
(1995)
Pharmacol. Biochem. Behav.
(1994)
gABA and the behavioural effects of anxiolytic drugs
Life Sci.
(1985)
Neurotransmitters, anxiety and benzodiazepines: a behavioral reveiw
Neurosci. Biobehav. Rev.
(1986)
Animal models for the study of anti-anxiety agents: a review
Neurosci. Biobehav. Rev.
(1985)
Anxiogenic stimuli in the elevated plus-maze
Pharmacol. biochem. Behav.
(1993)
Neuroplasticity in anxiety and defense
Risk assessment and animal models of anxiety
Anti-predator defensive behaviors in a visible burrow system
J. Comp. Psychol.
(1989)
Antipredator beahvior of Swiss-Webster mice in a visible burrow system
Aggress. Behav.
(1995)
Ethological approaches to the preclinical psychopharmacology of anxiety
Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against α2-adrenoceptor mediation
Psyhopharmacology
(1995)
An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze
Behav. Pharmacol.
(1993)
Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperiod
Pshychopharmacology
(1994)
Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze
Pharmacol. Biochem. Behav.
(1995)
GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus-maze procedures
Psychopharmacology
(1991)
Use of the elevated plus-maze to assess anxiolytic potential in the rat
Br. J. Pharmacol.
(1989)
Cited by (798)
MARK1 regulates dendritic spine morphogenesis and cognitive functions in vivo
2024, Experimental NeurologyAnalysis of the cognitive and functional behavior of female rats in the periestropause after hormone therapy with estrogen
2024, Behavioural Brain Research
Copyright © 1997 Published by Elsevier Ltd.